NOHA: A Promising Biomarker for Determining Estrogen Receptor Status Among Patients With Breast Cancer in Resource-Constrained Settings

Challenges to breast cancer control in low-and middle-income countries exist because of constrained access to care, including pathology services. Immunohistochemistry (IHC)–based estrogen receptor (ER) analysis is limited-nonexistent because of few and inadequately staffed and equipped pathology lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Serventi, Furaha, Musyoka, Augustine, Saunders, Jamie, Mremi, Alex, Mmbaga, Blandina Theophil, Patrick, Elizabeth, Mwakyembe, Theresia, Jones, Michael, Lucas, F. Lee., Miesfeldt, Susan, Mohan, Srinidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166386/
https://www.ncbi.nlm.nih.gov/pubmed/36542825
http://dx.doi.org/10.1200/GO.22.00192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166386/
https://www.ncbi.nlm.nih.gov/pubmed/36542825
http://dx.doi.org/10.1200/GO.22.00192

Ejemplares similares